These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 36199062)

  • 21. Alopecia areata: a tissue specific autoimmune disease of the hair follicle.
    Gilhar A; Kalish RS
    Autoimmun Rev; 2006 Jan; 5(1):64-9. PubMed ID: 16338213
    [TBL] [Abstract][Full Text] [Related]  

  • 22. SOCS3 treatment prevents the development of alopecia areata by inhibiting CD8+ T cell-mediated autoimmune destruction.
    Gao Z; Jin YQ; Wu W
    Oncotarget; 2017 May; 8(20):33432-33443. PubMed ID: 28418931
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Female pattern alopecia and telogen effluvium: figuring out diffuse alopecia.
    Torres F; Tosti A
    Semin Cutan Med Surg; 2015 Jun; 34(2):67-71. PubMed ID: 26176282
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interventions for alopecia areata.
    Delamere FM; Sladden MM; Dobbins HM; Leonardi-Bee J
    Cochrane Database Syst Rev; 2008 Apr; (2):CD004413. PubMed ID: 18425901
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recent advances in the pathogenesis of autoimmune hair loss disease alopecia areata.
    Ito T
    Clin Dev Immunol; 2013; 2013():348546. PubMed ID: 24151515
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Normalisation of hair follicle morphology in C3H/HeJ alopecia areata mice after treatment with squaric acid dibutylester.
    Gardner S; Freyschmidt-Paul P; Hoffmann R; Sundberg JP; Happle R; Lindsey NJ; Tobin DJ
    Eur J Dermatol; 2000 Aug; 10(6):443-50. PubMed ID: 10980465
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Alopecia areata: review of epidemiology, pathophysiology, current treatments and nanoparticulate delivery system.
    Singh R; Kumar P; Kumar D; Aggarwal N; Chopra H; Kumar V
    Ther Deliv; 2024 Mar; 15(3):193-210. PubMed ID: 38449420
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterizing the willingness to undergo treatment in patients with alopecia areata.
    O'Connor LF; Wells KM
    Arch Dermatol Res; 2022 Oct; 314(8):749-757. PubMed ID: 34609599
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluating the Therapeutic Potential of Ritlecitinib for the Treatment of Alopecia Areata.
    Ramírez-Marín HA; Tosti A
    Drug Des Devel Ther; 2022; 16():363-374. PubMed ID: 35210753
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alopecia areata: autoimmune basis of hair loss.
    Alexis AF; Dudda-Subramanya R; Sinha AA
    Eur J Dermatol; 2004; 14(6):364-70. PubMed ID: 15564197
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Changing Landscape of Alopecia Areata: An Introduction.
    Han G
    Adv Ther; 2017 Jul; 34(7):1584-1585. PubMed ID: 28646391
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Case Report of Alopecia Areata Treated with Individualized Homoeopathy.
    Bhasme A; Lamba P; Sajjan U
    Altern Ther Health Med; 2023 Apr; 29(3):92-96. PubMed ID: 34653026
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Failure of two TNF-alpha blockers to influence the course of alopecia areata.
    Abramovits W; Losornio M
    Skinmed; 2006; 5(4):177-81. PubMed ID: 16855408
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Alopecia areata: evidence-based treatments.
    Garg S; Messenger AG
    Semin Cutan Med Surg; 2009 Mar; 28(1):15-8. PubMed ID: 19341938
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Successful treatment of alopecia areata with Dr. Michaels® (Alopinex) product family.
    Wollina U; Hercogovấ J; Fioranelli M; Gianfaldoni S; Chokoeva AA; Tchernev G; Tirant M; Novotny F; Roccia MG; Maximov GK; França K; Lotti T
    J Biol Regul Homeost Agents; 2016; 30(2 Suppl 3):83-7. PubMed ID: 27498663
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Janus kinase inhibitors for the treatment of alopecia areata].
    Kobal I; Ramot Y
    Hautarzt; 2022 May; 73(5):336-343. PubMed ID: 35482047
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Successful treatment of alopecia areata-like hair loss with the contact sensitizer squaric acid dibutylester (SADBE) in C3H/HeJ mice.
    Freyschmidt-Paul P; Sundberg JP; Happle R; McElwee KJ; Metz S; Boggess D; Hoffmann R
    J Invest Dermatol; 1999 Jul; 113(1):61-8. PubMed ID: 10417620
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Can alopecia areata be triggered by emotional stress? An uncontrolled evaluation of 178 patients with extensive hair loss.
    van der Steen P; Boezeman J; Duller P; Happle R
    Acta Derm Venereol; 1992 Aug; 72(4):279-80. PubMed ID: 1357886
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alopecia in women.
    Thiedke CC
    Am Fam Physician; 2003 Mar; 67(5):1007-14. PubMed ID: 12643360
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hair transplantation for therapy-resistant alopecia areata of the eyebrows: is it the right choice?
    Civaş E; Aksoy B; Aksoy HM; Eski M; Yucel K
    J Dermatol; 2010 Sep; 37(9):823-6. PubMed ID: 20883369
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.